DM
David Mcauliffe
Non Executive Director at Invex Therapeutics
View David's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Non Executive Director
Mar 2019 - Present · 5 years and 9 months
2012 - Present · 12 years and 11 months
Executive Director
Nov 2016 - Present · 8 years and 1 months
Non Executive
2012 - 2016 · 4 years
Company Details
2-10 Employees
Invex Therapeutics (ASX: IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. Invex has trademarked its repurposed Exenatide as Presendin™.
Year Founded
2019
Social Media
Linkedin
Industry
Biotechnology Research, Pharmaceutical Manufacturing, Manufacturing Sector, General Medical and Surgical Hospitals, Health Care and Social Assistance
HQ Location
38 Rowland Street
Level 1
Subiaco, WA 6008, AU
Keywords
efficacious treatment
Contact Details
- Email AddressD**@invextherapeutics.comReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
Find verified contacts of David Mcauliffe in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.